Polypharmacy in the Elderly

Q4 Medicine Osteopathic Family Physician Pub Date : 2022-11-01 DOI:10.33181/13089
Kate L. Szymanski, Anu Garg, Megan Sizemore, Lindsey Loutzenhiser
{"title":"Polypharmacy in the Elderly","authors":"Kate L. Szymanski, Anu Garg, Megan Sizemore, Lindsey Loutzenhiser","doi":"10.33181/13089","DOIUrl":null,"url":null,"abstract":"Polypharmacy is the regular use of multiple medications and is often seen in older adults and individuals with multiple comorbidities. The commonly accepted definition of polypharmacy is the use of five or more medications by any individual. As patients become more multimorbid, the use of medication therapy increases and in turn raises the risk of polypharmacy. Polypharmacy is often associated with adverse outcomes, including increased mortality, falls, drug interactions, drug reactions, increased length of stay in the hospital, and increased readmission to the hospital after discharge. Patients over the age of 65 are often not included or well represented in drug trials, which can make medical decision-making challenging for evaluation of risk versus benefit in this patient population. There are several important factors to take note of when evaluating patients with polypharmacy.","PeriodicalId":53642,"journal":{"name":"Osteopathic Family Physician","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Osteopathic Family Physician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33181/13089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Polypharmacy is the regular use of multiple medications and is often seen in older adults and individuals with multiple comorbidities. The commonly accepted definition of polypharmacy is the use of five or more medications by any individual. As patients become more multimorbid, the use of medication therapy increases and in turn raises the risk of polypharmacy. Polypharmacy is often associated with adverse outcomes, including increased mortality, falls, drug interactions, drug reactions, increased length of stay in the hospital, and increased readmission to the hospital after discharge. Patients over the age of 65 are often not included or well represented in drug trials, which can make medical decision-making challenging for evaluation of risk versus benefit in this patient population. There are several important factors to take note of when evaluating patients with polypharmacy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
老年人的多药治疗
多药治疗是指经常使用多种药物,常见于老年人和患有多种合并症的人。普遍接受的多药治疗定义是任何个人使用五种或五种以上的药物。随着患者的多发病率越来越高,药物治疗的使用增加,从而增加了多药治疗的风险。多药治疗通常与不良后果有关,包括死亡率增加、跌倒、药物相互作用、药物反应、住院时间增加以及出院后再次入院人数增加。65岁以上的患者通常没有被纳入药物试验或在药物试验中有很好的代表性,这可能会使医疗决策对评估该患者群体的风险与收益具有挑战性。在评估多药治疗患者时,有几个重要因素需要注意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Osteopathic Family Physician
Osteopathic Family Physician Medicine-Family Practice
CiteScore
0.10
自引率
0.00%
发文量
17
期刊最新文献
Chronic Limb-Threatening Ischemia: Management Updates and Common Questions Application Of Osteopathic Treatment for Non-Pain–Related Discomforts of Pregnancy Human Parechovirus Meningoencephalitis In an Eight-Day-Old Infant Addressing Infertility and Other Reproductive Outcomes Among Female Physicians Integrating Behavioral Health and Primary Care
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1